000			02315 a2200673 4500
005			20250515174946.0
264		0	_c20091027
008			200910s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2009-02-203547 _2doi
040			_aNLM _beng _cNLM
100	1		_aFandy, Tamer E
245	0	0	_aEarly epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. _h[electronic resource]
260			_bBlood _cSep 2009
300			_a2764-73 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aAzacitidine _xadministration & dosage
650	0	4	_aBenzamides _xadministration & dosage
650	0	4	_aCytogenetic Analysis
650	0	4	_aDNA Damage _xdrug effects
650	0	4	_aDrug Administration Schedule
650	0	4	_aEpigenesis, Genetic _xdrug effects
650	0	4	_aFemale
650	0	4	_aHematologic Neoplasms _xdiagnosis
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrognosis
650	0	4	_aPyridines _xadministration & dosage
650	0	4	_aTime Factors
700	1		_aHerman, James G
700	1		_aKerns, Patrick
700	1		_aJiemjit, Anchalee
700	1		_aSugar, Elizabeth A
700	1		_aChoi, Si-Ho
700	1		_aYang, Allen S
700	1		_aAucott, Timothy
700	1		_aDauses, Tianna
700	1		_aOdchimar-Reissig, Rosalie
700	1		_aLicht, Jonathan
700	1		_aMcConnell, Melanie J
700	1		_aNasrallah, Chris
700	1		_aKim, Marianne K H
700	1		_aZhang, Weijia
700	1		_aSun, Yezou
700	1		_aMurgo, Anthony
700	1		_aEspinoza-Delgado, Igor
700	1		_aOteiza, Katharine
700	1		_aOwoeye, Ibitayo
700	1		_aSilverman, Lewis R
700	1		_aGore, Steven D
700	1		_aCarraway, Hetty E
773	0		_tBlood _gvol. 114 _gno. 13 _gp. 2764-73
856	4	0	_uhttps://doi.org/10.1182/blood-2009-02-203547 _zAvailable from publisher's website
999			_c18964345 _d18964345